Key result
Targeting the Nrf2 pathway shows promise for cardiovascular disease by suppressing oxidative stress.
Nuclear factor E2-related factor 2 (Nrf2) is a transcription factor that controls the basal and inducible expression of a battery of antioxidant genes and other cytoprotective Phase II detoxifying enzymes. Nrf2 is ubiquitously expressed in the cardiovascular system. While several Nrf2 downstream genes have been implicated in protection against the pathogenesis of cardiovascular diseases, the precise role of Nrf2 in the cardiovascular system remains to be elucidated. Nevertheless, mounting evidence has revealed that Nrf2 is a critical regulator of cardiovascular homeostasis via the suppression of oxidative stress, a major causative factor for the development and progression of cardiovascular diseases. Therefore, Nrf2 promises to be an attractive therapeutic target for the treatment of cardiovascular disease. Herein, we review the current literature that suggests that Nrf2 is a valuable therapeutic target for cardiovascular disease, as well as experiments that illustrate the mechanisms of Nrf2 cardioprotection.
No takes yet. Share an insight, caveat, or question.
Li et al. (2009) conducted a review in Cardiovascular disease. Nrf2 pathway targeting was evaluated. Targeting the Nrf2 pathway is a promising therapeutic strategy for cardiovascular disease by suppressing oxidative stress and regulating cardiovascular homeostasis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: